









市場行情
/
股票
/
nasdaq-ebs
/

Emergent BioSolutions Inc

EBS

12.430USD

-0.200-1.58%

收盤 12/26, 16:00（美東）報價延遲15分鐘

655.06M總市值

8.75本益比TTM



Emergent BioSolutions Inc

12.430

-0.200-1.58%

概覽公司財務分析

概覽

公司

財務

分析

關於 Emergent BioSolutions Inc 公司

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Emergent BioSolutions Inc簡介



公司代碼EBS

公司名稱Emergent BioSolutions Inc

上市日期Nov 15, 2006

CEOPapa (Joseph C)

員工數量900

證券類型Ordinary Share

年結日Nov 15

公司地址300 Professional Dr

城市GAITHERSBURG

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編20879

電話12406313200

網址https://emergentbiosolutions.com/

公司代碼EBS

上市日期Nov 15, 2006

CEOPapa (Joseph C)

Emergent BioSolutions Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

78.17K

-8.33%

Ms. Jessica Perl

Senior Vice President, General Counsel, Corporate Secretary

68.39K

+1061.66%

Mr. Marvin L. White

Independent Director

68.25K

+101.64%

Mr. Keith A. Katkin, CPA

Independent Director

66.14K

-10.60%

Mr. William Hartzel

Senior Vice President - Manufacturing and Bioservices

62.55K

-0.97%

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

78.17K

-8.33%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

地區USD

名稱

營收

佔比

Non-U.S Government

83.10M

58.98%

U.S.Government

57.80M

41.02%

業務

地區

業務USD

名稱

營收

佔比

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

7.43%

The Vanguard Group, Inc.

6.74%

State Street Investment Management (US)

4.66%

American Century Investment Management, Inc.

4.54%

Dimensional Fund Advisors, L.P.

4.08%

其他

72.56%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

7.43%

The Vanguard Group, Inc.

6.74%

State Street Investment Management (US)

4.66%

American Century Investment Management, Inc.

4.54%

Dimensional Fund Advisors, L.P.

4.08%

其他

72.56%

股東類型

持股股東

佔比

Investment Advisor

34.85%

Investment Advisor/Hedge Fund

30.34%

Hedge Fund

7.25%

Individual Investor

2.97%

Research Firm

1.58%

Pension Fund

1.08%

Bank and Trust

0.83%

Sovereign Wealth Fund

0.18%

Family Office

0.07%

其他

20.85%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

378

39.86M

83.14%

+128.30K

2025Q3

417

39.73M

84.87%

+2.04M

2025Q2

439

37.58M

87.40%

+1.14M

2025Q1

454

36.44M

84.55%

-9.64M

2024Q4

461

35.04M

82.31%

+2.84M

2024Q3

467

32.21M

81.37%

+1.29M

2024Q2

485

30.86M

99.60%

-5.54M

2024Q1

494

36.44M

103.37%

-17.72M

2023Q4

512

41.89M

103.68%

-1.06M

2023Q3

563

42.52M

113.85%

-6.21M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

3.83M

7.18%

+2.25M

+141.83%

Jun 30, 2025

The Vanguard Group, Inc.

3.58M

6.72%

+370.21K

+11.52%

Jun 30, 2025

State Street Investment Management (US)

1.74M

3.26%

+30.01K

+1.75%

Jun 30, 2025

American Century Investment Management, Inc.

2.29M

4.3%

-5.46K

-0.24%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.85M

3.47%

+252.40K

+15.81%

Jun 30, 2025

Palisade Capital Management, LLC

1.10M

2.06%

-41.83K

-3.66%

Jun 30, 2025

Charles Schwab Investment Management, Inc.

1.11M

2.07%

+521.91K

+89.48%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.28M

2.4%

+666.71K

+108.89%

Jun 30, 2025

Acadian Asset Management LLC

974.59K

1.83%

+141.27K

+16.95%

Jun 30, 2025

Connor, Clark & Lunn Investment Management Ltd.

986.67K

1.85%

+55.05K

+5.91%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

AdvisorShares Insider Advantage ETF

0.97%

Royce Quant Small-Cap Quality Value ETF

0.41%

State Street SPDR S&P Biotech ETF

0.28%

Federated Hermes MDT Small Cap Core ETF

0.23%

Harbor Human Capital Factor US Small Cap ETF

0.19%

Direxion Daily S&P Biotech Bull 3X Shares

0.18%

Pacer US Small Cap Cash Cows ETF

0.16%

Invesco RAFI US 1500 Small-Mid ETF

0.15%

Avantis US Small Cap Value ETF

0.14%

iShares Micro-Cap ETF

0.13%

AdvisorShares Insider Advantage ETF

佔比0.97%

Royce Quant Small-Cap Quality Value ETF

佔比0.41%

State Street SPDR S&P Biotech ETF

佔比0.28%

Federated Hermes MDT Small Cap Core ETF

佔比0.23%

Harbor Human Capital Factor US Small Cap ETF

佔比0.19%

Direxion Daily S&P Biotech Bull 3X Shares

佔比0.18%

Pacer US Small Cap Cash Cows ETF

佔比0.16%

Invesco RAFI US 1500 Small-Mid ETF

佔比0.15%

Avantis US Small Cap Value ETF

佔比0.14%

iShares Micro-Cap ETF

佔比0.13%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Emergent BioSolutions Inc的前五大股東是誰？



Emergent BioSolutions Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：3.83M
佔總股份比例：7.18%。
The Vanguard Group, Inc.
持有股份：3.58M
佔總股份比例：6.72%。
State Street Investment Management (US)
持有股份：1.74M
佔總股份比例：3.26%。
American Century Investment Management, Inc.
持有股份：2.29M
佔總股份比例：4.30%。
Dimensional Fund Advisors, L.P.
持有股份：1.85M
佔總股份比例：3.47%。